Personalized interventional oncology is a novel therapy development with ability to provide enhanced genomic and tumoral mechanistic information of the patient. It is set to play an integral part of oncologic patient care with treatment based on clinical decisions tailored to patient?s molecular profile.
The report ?Global Interventional Oncology Market - (By Therapy - Radiation Therapy, Particle Embolization & Ablation; By Region- North America, Europe & Asia Pacific) Market Outlook 2024? provides in-depth analysis of the current scenario, detailed market outlook of the global interventional oncology market overall as well as across various sub-segments such as Radiation Therapy, Particle Embolization & Ablation for the period 2018-24. Regional analysis is done across major markets in North America, Europe and Asia Pacific.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global interventional oncology market. The report has been segmented as following:-
Market Segments
? Radiation Therapy
? Particle Embolization
? Ablation
Geographical Coverage
? North America
? Europe
? Asia Pacific
Key Vendors
? Boston Scientific Corporation
? Accuray Incorporated
? Medtronic PLC
? Terumo Corporation
? Merit Medical Systems, Inc.
? BTG PLC


Interventional oncology is a rapidly growing field of interventional oncology which deals with diagnosis and treatment of cancer using minimally invasive procedures. It uses various imaging techniques such as x-ray, ultrasound, computed tomography, or magnetic resonance imaging for guidance purposes. Interventional oncology is general employed for treatment of liver cancer, lung cancer, bone cancer, kidney cancer, prostate cancer, breast cancer, and pancreatic cancer. Interventional oncology treatment market is segmented into Radiation therapy, Ablation, and Particle embolization on the basis of procedure.
Interventional oncology is expected to become the fourth pillar of cancer care, with medical, surgical, and radiation oncology. It provides with minimally invasive treatment option while mitigating various associated risks. Growth of the global interventional oncology market is propelled by rising oncology incidences, growing demand for minimally invasive therapeutics and increasing geriatric population. However, the market faces several challenges due to high treatment cost, associated risk and presence of alternative treatment options.
The report ?Global Interventional Oncology Market - (By Therapy - Radiation Therapy, Particle Embolization & Ablation; By Region- North America, Europe & Asia Pacific) Market Outlook 2024? provides in-depth analysis of the current scenario, detailed market outlook of the global interventional oncology market with coverage on major market segments such as Radiation Therapy, Particle Embolization & Ablation. Future forecasts of interventional oncology market overall and across various market segments has been provided in the report till 2024. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global interventional oncology market include Boston Scientific Corporation, Accuray Incorporated, Medtronic PLC, Terumo Corporation, Merit Medical Systems, Inc., BTG PLC, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global interventional oncology market.